{"id":709575,"date":"2026-04-06T21:49:13","date_gmt":"2026-04-06T21:49:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/709575\/"},"modified":"2026-04-06T21:49:13","modified_gmt":"2026-04-06T21:49:13","slug":"ann-arbor-pharmaceutical-company-acquires-nasal-spray-treatment-manufacturer-mlive-com","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/709575\/","title":{"rendered":"Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer – MLive.com"},"content":{"rendered":"
    \n
  1. Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer<\/a>  MLive.com<\/li>\n
  2. Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio<\/a>  The Globe and Mail<\/li>\n
  3. Esperion Adds $25 Million Term Loans, Sells $50 Million Otsuka Royalties to Fund Corstasis Buy<\/a>  TradingView<\/li>\n
  4. Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst\u2122 (bumetanide nasal spray)<\/a>  Yahoo Finance<\/li>\n
  5. Esperion completes acquisition of Corstasis Therapeutics<\/a>  Investing.com<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer  MLive.com Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio  The Globe and…\n","protected":false},"author":3,"featured_media":231978,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-709575","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116359971943505058","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/709575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=709575"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/709575\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/231978"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=709575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=709575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=709575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}